<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//beonemedaffairs.kinsta.cloud/it/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/%post_id%/</loc>
		<lastmod>2024-03-21T13:36:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/2569/bgb-a445-tislelizumab-sitravatinib-mulitkinase-inhibitor-bgb-15025-hpk1-inhibitor-chemotherapy/</loc>
		<lastmod>2024-03-21T13:27:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/2480/tislelizumab-surzebiclimab-lbl-007/</loc>
		<lastmod>2024-03-21T13:27:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/2479/lbl-007-tislelizumab-chemotherapy/</loc>
		<lastmod>2024-03-21T13:28:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/2478/bgb-a3055-anti-ccr8-tislelizumab/</loc>
		<lastmod>2024-03-21T13:28:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/2477/bgb-30813-dgk%ce%b6-inhibitor-tislelizumab/</loc>
		<lastmod>2024-03-21T13:28:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/2476/bgb-26808-hpk1-inhibitor-tislelizumab-anti-pd-1/</loc>
		<lastmod>2024-03-21T13:28:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/1925/tislelizumab-ociperlimab-lbl-007/</loc>
		<lastmod>2024-03-21T13:28:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/1924/bgb-b167-cea-4-1bb-bispecific-antibody-tislelizumab-anti-pd-1/</loc>
		<lastmod>2024-03-21T13:28:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/1439/ociperlimab-anti-tigit-tislelizumab-or-rituximab/</loc>
		<lastmod>2024-03-21T13:28:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/1433/bgb-24714-smac-mimetic-chemotherapy/</loc>
		<lastmod>2024-03-21T13:28:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/474/zanidatamab-chemotherapy-tislelizumab/</loc>
		<lastmod>2024-03-21T13:28:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/473/zanidatamab-anti-her2-bispecific-antibody/</loc>
		<lastmod>2024-03-21T13:28:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/472/tislelizumab-surufatinib-vegfr-fgfr-csf-1r-inhibitor/</loc>
		<lastmod>2024-03-21T13:28:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/470/tislelizumab-lenvatinib-vegfr-kinase-inhibitor/</loc>
		<lastmod>2024-03-21T13:29:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/467/tislelizumab-chemotherapy/</loc>
		<lastmod>2024-03-21T13:31:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/466/tislelizumab-chemotherapy-chemoradiotherapy/</loc>
		<lastmod>2024-03-21T13:31:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/465/tislelizumab-chemoradiotherapy/</loc>
		<lastmod>2024-03-21T13:31:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/464/tislelizumab-bgb-15025-hpk1-inhibitor/</loc>
		<lastmod>2024-03-21T13:32:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/457/ociperlimab-tislelizumab-concurrent-chemoradiotherapy/</loc>
		<lastmod>2024-03-21T13:32:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/456/ociperlimab-tislelizumab-chemotherapy/</loc>
		<lastmod>2024-03-21T13:32:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/455/ociperlimab-tislelizumab-bat1706-anti-vegf/</loc>
		<lastmod>2024-03-21T13:32:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/453/lifirafenib-raf-inhibitor-mirdametinib-mek-inhibitor/</loc>
		<lastmod>2024-03-21T13:32:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/452/bgb-3245-braf-inhibitor/</loc>
		<lastmod>2024-03-21T13:32:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/448/zanubrutinib-lenalidomide-rituximab/</loc>
		<lastmod>2024-03-21T13:32:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/445/bgb-16673-btk-targeted-cdac/</loc>
		<lastmod>2024-03-21T13:36:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/444/bgb-11417-monotherapy-zanubrutinib/</loc>
		<lastmod>2024-03-21T13:36:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/443/bgb-11417-dexamethasone-carfilzomib/</loc>
		<lastmod>2024-03-21T13:36:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/442/bgb-11417-azacitidine-posaconazole/</loc>
		<lastmod>2024-03-21T13:36:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/441/bgb-11417-bcl-2-inhibitor-monotherapy/</loc>
		<lastmod>2024-03-21T13:36:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/439/bgb-10188-pi3k%ce%b4-inhibitor-tislelizumab/</loc>
		<lastmod>2024-03-21T13:36:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://beonemedaffairs.kinsta.cloud/it/pipelines/438/tislelizumab-anti-pd1/</loc>
		<lastmod>2024-03-21T13:36:42+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->